MK-8527 / Merck (MSD)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MK-8527 / Merck (MSD)
NCT03615183: A Study of MK-8527 in Human Immunodeficiency Type 1 Virus (HIV-1) Infected Participants (MK-8527-002)

Completed
1
17
Europe
MK-8527
Merck Sharp & Dohme LLC
Human Immunodeficiency Virus, AIDS Virus
09/19
09/19
MK-8527-004, NCT05494736: MK-8527 Single-Dose Trial in HIV-1 Infected Participants

Completed
1
20
Europe, RoW
MK-8527
Merck Sharp & Dohme LLC
Human Immunodeficiency Virus
01/24
01/24
MK-8527-008, NCT06295796: A Study of MK-8527 in Participants With Moderate and Severe Renal Impairment

Recruiting
1
18
US
MK-8527
Merck Sharp & Dohme LLC
Renal Impairment
04/25
04/25

Download Options